Asimov Stock
HealthTechLooking to sell Asimov stock or options?
Asimov develops mammalian cell engineering software aimed at accelerating the design and production of biologics and gene therapies. The company's platform integrates synthetic biology, biophysical simulations, and machine learning-based design to engineer genetic circuits within the biotechnology sector. This enables healthcare companies to optimize the creation and design of genetic logic gates, facilitating advanced manufacturing processes and therapeutic applications.
Casdin Capital, Wing Venture Capital, Pillar VC, Frog Design, Horizons Ventures, AME Cloud Ventures, CLF Partners, MIT Startup Exchange, iGem Startups, Liquid 2 Ventures, FMR (United States), Koch Disruptive Technologies, Andreessen Horowitz, CPP Investments, K5 Global, KdT Ventures, DCVC.